Portal vein thrombosis;Trombosis portal

Gastroenterologia y Hepatologia

Volumn 33, Issue 3, 2010, Pages 179-190

  Seijo Ríos, Susana ^a   García Pagán, Juan Carlos ^a  

^a Institut Clinic de Malalties Digestives i Metaboliques   (Spain)

Author keywords

Gastrointestinal variceal bleeding; JAK2 mutation; Myeloproliferative syndrome; Portal hypertension

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; JANUS KINASE 2; LOW MOLECULAR WEIGHT HEPARIN; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ANTICOAGULANT THERAPY; ARTICLE; BILE DUCT DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE SYSTEM HEMORRHAGE; ENDOSCOPIC SURGERY; GENE MUTATION; HUMAN; INTESTINE ISCHEMIA; NAUSEA; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PREGNANCY; PROGNOSIS; RECANALIZATION; SPLENOMEGALY; THROMBOCYTOPENIA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; CONTRACEPTIVES, ORAL, HORMONAL; DIAGNOSTIC IMAGING; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GALLBLADDER DISEASES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; MALE; MYELOPROLIFERATIVE DISORDERS; NEOPLASMS; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREVALENCE; THROMBOPHILIA; VASOCONSTRICTOR AGENTS; VENOUS THROMBOSIS;

EID: 77049118481     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.04.002     Document Type: Article

References (60)

1. Valla D.C., and Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32 (2000) 865-871
2. Sarin S.K., and Agarwal S.R. Extrahepatic portal vein obstruction. Semin Liver Dis 22 (2002) 43-58
3. García-Pagán J.C., Hernández-Guerra M., and Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis 28 (2008) 282-292
4. Valla D.C., Condat B., and Lebrec D. Spectrum of portal vein thrombosis in the West. J Gastroenterol Hepatol 17 (2002) S224-S227
5. Sarin S.K., Sollano J.D., Chawla Y.K., Amarapurkar D., Hamid S., Hashizume M., et al. Consensus on extra-hepatic portal vein obstruction. Liver Int 26 (2006) 512-519
6. Primignani M., and Mannucci P.M. The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 28 (2008) 293-301
7. Denninger M.H., Chait Y., Casadevall N., Hillaire S., Guillin M.C., Bezeaud A., et al. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors. Hepatology 31 (2000) 587-591
8. Janssen H.L., Meinardi J.R., Vleggaar F.P., Van Uum S.H., Haagsma E.B., Van Der Meer F.J., et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study. Blood 96 (2000) 2364-2368
9. Primignani M., Martinelli I., Bucciarelli P., Battaglioli T., Reati R., Fabris F., et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41 (2005) 603-608
10. Rosendaal F.R. Venous thrombosis: A multicausal disease. Lancet 353 (1999) 1167-1173
11. Valla D., Casadevall N., Huisse M.G., Tulliez M., Grange J.D., Muller O., et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94 (1988) 1063-1069
12. Bittencourt P.L., Couto C.A., and Ribeiro D.D. Portal vein thrombosis and Budd-Chiari syndrome. Clin Liver Dis 13 (2009) 127-144
13. Baxter E.J., Scott L.M., Campbell P.J., East C., Fourouclas N., Swanton S., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
14. Kiladjian J.J., Cervantes F., Leebeek F.W., Marzac C., Cassinat B., Chevret S., et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: A report on 241 cases. Blood 111 (2008) 4922-4929
15. Primignani M., Barosi G., Bergamaschi G., Gianelli U., Fabris F., Reati R., et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44 (2006) 1528-1534
16. Tefferi A., Thiele J., Orazi A., Kvasnicka H.M., Barbui T., Hanson C.A., et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood 110 (2007) 1092-1097
17. De Bruijne E.L., Murad S.D., De Maat M.P., Tanck M.W., Haagsma E.B., Van Hoek B., et al. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis. Thromb Haemost 97 (2007) 181-185
18. Perarnau J.M., and Bacq Y. Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy. Semin Liver Dis 28 (2008) 315-327
19. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
20. Pinto R.B., Silveira T.R., Bandinelli E., and Rohsig L. Portal vein thrombosis in children and adolescents: The low prevalence of hereditary thrombophilic disorders. J Pediatr Surg 39 (2004) 1356-1361
21. Cazals-Hatem D., Vilgrain V., Genin P., Denninger M.H., Durand F., Belghiti J., et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: A study in 17 explanted livers. Hepatology 37 (2003) 510-519
22. Murad S.D., Valla D.C., De Groen P.C., Zeitoun G., Haagsma E.B., Kuipers E.J., et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 101 (2006) 83-90
23. Plessier A MS, Hernández-Guerra M et al. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): Results from the European Network for Vascular Disorders of the Liver. Hepatology. 2007;46 En prensa.
24. Harmanci O., and Bayraktar Y. Portal hypertension due to portal venous thrombosis: Etiology, clinical outcomes. World J Gastroenterol 13 (2007) 2535-2540
25. Turnes J., García-Pagan J.C., González M., Aracil C., Calleja J.L., Ripoll C., et al. Portal hypertension-related complications after acute portal vein thrombosis: Impact of early anticoagulation. Clin Gastroenterol Hepatol 6 (2008) 1412-1417
26. Amitrano L., Guardascione M.A., Scaglione M., Pezzullo L., Sangiuliano N., Armellino M.F., et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 102 (2007) 2464-2470
27. Condat B., Pessione F., Helene Denninger M., Hillaire S., and Valla D. Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32 (2000) 466-470
28. Álvarez F., Bernard O., Brunelle F., Hadchouel P., Odievre M., and Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr 103 (1983) 696-702
29. Sarin S.K., and Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis 10 (2006) 627-651 x
30. Condat B., Pessione F., Hillaire S., Denninger M.H., Guillin M.C., Poliquin M., et al. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy. Gastroenterology 120 (2001) 490-497
31. Janssen H.L. Role of coagulation in the natural history and treatment of portal vein thrombosis. J Gastroenterol Hepatol 16 (2001) 595-596
32. Condat B., and Valla D. Portal vein thrombosis. Presse Med 32 (2003) 1460-1465
33. Khuroo M.S., Yattoo G.N., Zargar S.A., Javid G., Dar M.Y., Khan B.A., et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology 17 (1993) 807-813
34. Htun Oo Y., Olliff S., Haydon G., and Thorburn D. Symptomatic portal biliopathy: A single centre experience from the UK. Eur J Gastroenterol Hepatol 21 (2009) 206-213
35. Sarin S.K., Bansal A., Sasan S., and Nigam A. Portal-vein obstruction in children leads to growth retardation. Hepatology 15 (1992) 229-233
36. Dhiman R.K., Puri P., Chawla Y., Minz M., Bapuraj J.R., Gupta S., et al. Biliary changes in extrahepatic portal venous obstruction: Compression by collaterals or ischemic?. Gastrointest Endosc 50 (1999) 646-652
37. Sezgin O., Oguz D., Altintas E., Saritas U., and Sahin B. Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein. Gastrointest Endosc 58 (2003) 602-608
38. Minguez B., García-Pagán J.C., Bosch J., Turnes J., Alonso J., Rovira A., et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 43 (2006) 707-714
39. Fisher N.C., Wilde J.T., Roper J., and Elías E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: A secondary phenomenon?. Gut 46 (2000) 534-539
40. Ueno N., Sasaki A., Tomiyama T., Tano S., and Kimura K. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein. J Clin Ultrasound 25 (1997) 227-233
41. Lee H.K., Park S.J., Yi B.H., Yeon E.K., Kim J.H., and Hong H.S. Portal vein thrombosis: CT features. Abdom Imaging 33 (2008) 72-79
42. Okumura A., Watanabe Y., Dohke M., Ishimori T., Amoh Y., Oda K., et al. Contrast-enhanced three-dimensional MR portography. Radiographics 19 (1999) 973-987
43. Dolovich L.R., Ginsberg J.S., Douketis J.D., Holbrook A.M., and Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 160 (2000) 181-188
44. Hollingshead M., Burke C.T., Mauro M.A., Weeks S.M., Dixon R.G., and Jaques P.F. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 651-661
45. Pfammatter T., Benoit C., Cathomas G., and Blum U. Budd-Chiari syndrome with spleno-mesenteric-portal thrombosis: Treatment with extended TIPS. J Vasc Interv Radiol 11 (2000) 781-784
46. Senzolo M., Cholongitas E., Davies N., Marelli N., Shusang V., Patch D., et al. Transjugular intrahepatic portosystemic shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis. Am J Gastroenterol 101 (2006) 2163-2164 author reply 4-5
47. Chawla Y.K., Dilawari J.B., Ramesh G.N., Kaur U., Mitra S.K., and Walia B.N. Sclerotherapy in extrahepatic portal venous obstruction. Gut 31 (1990) 213-216
48. Spaander M.C., Murad S.D., Van Buuren H.R., Hansen B.E., Kuipers E.J., and Janssen H.L. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: A long-term follow-up study. Gastrointest Endosc 67 (2008) 821-827
49. Senzolo M., Tibbals J., Cholongitas E., Triantos C.K., Burroughs A.K., and Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 23 (2006) 767-775
50. Orloff M.J., Orloff M.S., Girard B., and Orloff S.L. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg 194 (2002) 717-728 discussion 28-30
51. De Ville de Goyet J., Gibbs P., Clapuyt P., Reding R., Sokal E.M., and Otte J.B. Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results. Transplantation 62 (1996) 71-75
52. Superina R., Bambini D.A., Lokar J., Rigsby C., and Whitington P.F. Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass. Ann Surg 243 (2006) 515-521
53. Vanderlan W.B., Bansal A., and Abouljoud M.S. Adult portal hypertension secondary to posttraumatic extrahepatic portal vein thrombosis treated with Rex shunt. J Trauma 66 (2009) 260-263
54. Yamamoto S., Sato Y., Oya H., Nakatsuka H., Watanabe T., Takizawa K., et al. Splenic-intrahepatic left portal shunt in an adult patient with extrahepatic portal vein obstruction without recurrence after pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg 16 (2009) 86-89
55. Condat B., Vilgrain V., Asselah T., O'Toole D., Rufat P., Zappa M., et al. Portal cavernoma-associated cholangiopathy: A clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 37 (2003) 1302-1308
56. Dumortier J., Vaillant E., Boillot O., Poncet G., Henry L., Scoazec J.Y., et al. Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy 35 (2003) 446-450
57. Bhatia V., Jain A.K., and Sarin S.K. Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: Management with endoscopic sphincterotomy. Gastrointest Endosc 42 (1995) 178-181
58. Vibert E., Azoulay D., Aloia T., Pascal G., Veilhan L.A., Adam R., et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg 246 (2007) 97-104
59. Hajdu C.H., Murakami T., Diflo T., Taouli B., Laser J., Teperman L., et al. Intrahepatic portal cavernoma as an indication for liver transplantation. Liver Transpl 13 (2007) 1312-1316
60. Janssen H.L., Wijnhoud A., Haagsma E.B., Van Uum S.H., Van Nieuwkerk C.M., Adang R.P., et al. Extrahepatic portal vein thrombosis: Aetiology and determinants of survival. Gut 49 (2001) 720-724